| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Channing Laboratory, and
Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA 02115; and
Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115
We investigated the role of complement component C1q in the IgG-independent opsonophagocytosis of type III group B Streptococcus (GBS) by peripheral blood leukocytes. We report that C1q binds to type III GBS both in normal human serum deficient in IgG specific for type III capsular polysaccharide and in a low-ionic strength buffer. The dissociation constant Kd ranged from 2.0 to 5.5 nM, and the number of binding sites Bmax ranged from 630 to 1360 molecules of C1q per bacterium (CFU). An acapsular mutant strain of GBS bound C1q even better than the wild type, indicating that the polysaccharide capsule is not the receptor for C1q. In serum, binding of C1q to GBS was associated with activation of the classical complement pathway. However, normal human serum retained significant opsonic activity after complete depletion of C1q, suggesting that the serum contains a molecule that is able to replace C1q in opsonization and/or complement activation. Mannan-binding lectin, known to share some functions with C1q, appeared not to be involved, since its depletion from serum had little effect on opsonic activity. Excess soluble C1q or its collagen-like fragment inhibited phagocytosis mediated by normal human serum, suggesting that C1q may compete with other opsonins for binding to receptor(s) on phagocytes. We conclude that, although C1q binds directly to GBS, C1q binding is neither necessary nor sufficient for IgG-independent opsonophagocytosis. The results raise the possibility that additional unknown serum factor(s) may contribute to opsonization of GBS directly or via a novel mechanism of complement activation.
This article has been cited by other articles:
|
|
 |
|
  A. Hamilton, D. L. Popham, D. J. Carl, X. Lauth, V. Nizet, and A. L. Jones Penicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides. Infect. Immun., November 1, 2006; 74(11): 6179 - 6187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yuste, S. Ali, S. Sriskandan, C. Hyams, M. Botto, and J. S. Brown Roles of the Alternative Complement Pathway and C1q during Innate Immunity to Streptococcus pyogenes J. Immunol., May 15, 2006; 176(10): 6112 - 6120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Aoyagi, E. E. Adderson, J. G. Min, M. Matsushita, T. Fujita, S. Takahashi, Y. Okuwaki, and J. F. Bohnsack Role of L-Ficolin/Mannose-Binding Lectin-Associated Serine Protease Complexes in the Opsonophagocytosis of Type III Group B Streptococci J. Immunol., January 1, 2005; 174(1): 418 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Levy, R. M. Jean-Jacques, C. Cywes, R. B. Sisson, K. A. Zarember, P. J. Godowski, J. L. Christianson, H.-K. Guttormsen, M. C. Carroll, A. Nicholson-Weller, et al. Critical Role of the Complement System in Group B Streptococcus-Induced Tumor Necrosis Factor Alpha Release Infect. Immun., November 1, 2003; 71(11): 6344 - 6353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Brown, T. Hussell, S. M. Gilliland, D. W. Holden, J. C. Paton, M. R. Ehrenstein, M. J. Walport, and M. Botto The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice PNAS, December 24, 2002; 99(26): 16969 - 16974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Watford, M. B. Smithers, M. M. Frank, and J. R. Wright Surfactant protein A enhances the phagocytosis of C1q-coated particles by alveolar macrophages Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1011 - L1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Grace, R. A. Bronson, and B. Ghebrehiwet Surface Expression of Complement Receptor gC1q-R/p33 Is Increased on the Plasma Membrane of Human Spermatozoa after Capacitation Biol Reprod, March 1, 2002; 66(3): 823 - 829. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
